Physician profile
Drew Edwards
NPI 1487744934
$1,801.04
in general payments reported to CMS, 2019-2025
20 companies · $18.85 in 2025
The $18.85 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,764 · 2024: $17.74 · 2025: $18.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $18.85 · Food and Beverage: $17.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $18.85 |
| Food and Beverage | $17.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.42 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $168.20 | 2019-2024 | Airsupra |
| Glaxosmithkline, LLC. | $165.69 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $142.51 | 2019 | |
| Novo Nordisk INC | $132.27 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.09 | 2019 | |
| Pfizer INC. | $96.09 | 2019 | |
| Lilly USA, LLC | $89.95 | 2019 | |
| Merck Sharp & Dohme LLC | $78.65 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $75.10 | 2019 | |
| Allergan, INC. | $74.90 | 2019 | |
| Sanofi Pasteur INC. | $36.67 | 2019 | |
| Aytu Biopharma, INC. | $29.66 | 2019 | |
| Amgen INC. | $23.12 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.98 | 2019 | |
| Astellas Pharma US INC | $22.31 | 2019 | |
| Indivior INC. | $20.27 | 2019 | |
| Abbvie INC. | $15.82 | 2019 | |
| Shire North American Group INC | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.